Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk
- DOI
- 10.1136/ejhpharm-2026-005143
- Published
- 2026-06-03
- Container
- European Journal of Hospital Pharmacy
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/ejhpharm-2026-005143,
title = {Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk},
author = {Alejandro Rodríguez Rodríguez and Sandra Caíña López and Tania González Fernández and Paula María Alonso Gago},
year = {2026},
journal = {European Journal of Hospital Pharmacy},
doi = {10.1136/ejhpharm-2026-005143},
url = {https://doi.org/10.1136/ejhpharm-2026-005143}
}RIS
TY - JOUR TI - Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk AU - Alejandro Rodríguez Rodríguez AU - Sandra Caíña López AU - Tania González Fernández AU - Paula María Alonso Gago PY - 2026 JO - European Journal of Hospital Pharmacy DO - 10.1136/ejhpharm-2026-005143 UR - https://doi.org/10.1136/ejhpharm-2026-005143 ER -
APA
Rodríguez, A. R., López, S. C., Fernández, T. G., & Gago, P. M. A. (2026). Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk. European Journal of Hospital Pharmacy. https://doi.org/10.1136/ejhpharm-2026-005143
Source records
- crossref · retrieved 2026-09-25T17:56:17.108Z